VEGF Trap-Eye: Additional Phase II data

Thirty-two week follow-up data from the double-blind Phase II CLEAR-IT 2 trial in 157 patients showed that intravitreal VEGF Trap-Eye, when dosed on an as-needed basis following the initial 12-week tr...